Search - tctmd.com

Displaying 641 - 660 of 2040

Sort: Relevancy | Date

Presentation TVT 2022

LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management

Presenter: Vinayak N. Bapat

June 10, 2022

Presentation TVT 2022

Myocardial Intramural Remodeling by Transvenous Interstitial teTHer

Presenter: Christopher Bruce

June 10, 2022

Presentation TVT 2022

The Carillon Mitral Contour System for Treating HF With MR

Presenter: Randall Starling

June 10, 2022

Presentation TVT 2022

The Accucinch Ventricular Restoration System for HFrEF

Presenter: Ulrich Jorde

June 10, 2022

Presentation TVT 2022

Rationale for Physical Reverse LV Remodeling as a Therapy for HFrEF

Presenter: Daniel Burkhoff

June 10, 2022

Presentation TVT 2022

Transcatheter Decommissioning of the Left Ventricular Assist Device in Post TAVR Recovered LV Systolic Function Patient

Presenter: Tuncay Taskesen

June 10, 2022

Presentation TVT 2022

Mitral Transcatheter Edge-to-Edge Repair for Dynamic LVOT Obstruction

Presenter: Tim Hinohara

June 10, 2022

Presentation TVT 2022

Design and Rationale of the CORCINCH-HF Pivotal Study

Presenter: Ulrich Jorde

June 09, 2022

Presentation TVT 2022

12-Month Outcomes for the AccuCinch System in HFrEF

Presenter: Nadira Hamid

June 09, 2022

Presentation TVT 2022

From Access to Anchors: The AccuCinch Ventricular Restoration System

Presenter: Azeem Latib

June 09, 2022

Presentation TVT 2022

Reverse Remodeling in Heart Failure

Presenter: Daniel Burkhoff

June 09, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

A CASE OF… Severe Functional Mitral Regurgitation in End-Stage HF: TEER as Bridge or Alternative to LVAD/Transplant

Presenter: Ulrich Jorde

June 09, 2022

Presentation TVT 2022

#2 Case Resolution: Acute LVOT Obstruction Post-TMVR

Presenter: Adam Greenbaum

June 08, 2022

Presentation TVT 2022

#2 Case Presentation: Acute LVOT Obstruction Post-TMVR

Presenter: Adam Greenbaum

June 08, 2022

News Daily News

Heart Failure Risks of Smoking Can Linger for Decades

L.A. McKeown

June 07, 2022

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Todd Neale

May 31, 2022

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Conference News EuroPCR 2022

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Caitlin E. Cox

May 25, 2022

News Conference News ESC Heart Failure 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Shelley Wood

May 23, 2022

Advertisement

LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management

Myocardial Intramural Remodeling by Transvenous Interstitial teTHer

The Carillon Mitral Contour System for Treating HF With MR

The Accucinch Ventricular Restoration System for HFrEF

Rationale for Physical Reverse LV Remodeling as a Therapy for HFrEF

Transcatheter Decommissioning of the Left Ventricular Assist Device in Post TAVR Recovered LV Systolic Function Patient

Mitral Transcatheter Edge-to-Edge Repair for Dynamic LVOT Obstruction

Design and Rationale of the CORCINCH-HF Pivotal Study

12-Month Outcomes for the AccuCinch System in HFrEF

From Access to Anchors: The AccuCinch Ventricular Restoration System

Reverse Remodeling in Heart Failure

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

A CASE OF… Severe Functional Mitral Regurgitation in End-Stage HF: TEER as Bridge or Alternative to LVAD/Transplant

#2 Case Resolution: Acute LVOT Obstruction Post-TMVR

#2 Case Presentation: Acute LVOT Obstruction Post-TMVR

Heart Failure Risks of Smoking Can Linger for Decades

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content